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Aromatization of testosterone by cultured Sertoli cells isolated from immature rats was stimulated more 
than 7-fold by follicle stimulating hormone (FSH) or dcAMP. The effects of FSH and dcAMP could be 
partly inhibited by epidermal growth factor (EGF) in a dose-dependent manner (IDs0 0.5 nM). The phorbol 
ester 4fl-phorbol-12-myristate-13-acetate (PMA) could also inhibit aromatase activity in a fashion similar 
to EGF. When 3 mM EGTA was present in the culture medium, the inhibitory effect of EGF was abolished 
but the stimulatory effect of FSH or dcAMP was magnified. These results uggest that EGF exerts a negative 
control on aromatase via calcium and protein kinase C. The abolishment of the inhibitory effect of EGF 
and the enhancement ofthe stimulatory effect of FSH or dcAMP by a calcium deficiency may be an indica- 
tion that growth factors produced by Sertoli cells negatively control FSH-induced responses in an autocrine 
fashion. 
Aromatization; EGF; Ca 2 +; Phorbol ester; (Sertoli cell) 
1. INTRODUCTION 
The Sertoli cells in immature rats are an impor- 
tant source of intratesticular oestradiol [1]. Follicle 
stimulating hormone (FSH) stimulates the 
aromatization of testosterone probably via cyclic 
adenosine monophosphate (cAMP). After addi- 
tion of serum to Sertoli cells this stimulatory effect 
of FSH on oestradiol production was inhibited [3]. 
In a previous paper we have shown that EGF may 
be one of the active principles in serum responsible 
for this inhibitory effect since EGF inhibits the 
FSH-stimulated aromatization i  Sertoli cells from 
immature rats whereas insulin had no effect [4]. 
The inhibition of FSH-stimulated aromatization 
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by EGF occurred in parallel with the stimulation of 
lactate production [4]. It is unknown which in- 
tracellular mediators are involved in this specific 
inhibitory effect of EGF on at least one of the 
many functions of Sertoli cells [5]. 
It has been shown that addition of EGF or foetal 
calf serum (FCS) to fibroblasts caused a rise in the 
cytoplasmic levels of Ca z+, whereas insulin did not 
modify these levels. Therefore, it was suggested 
that a rise in the intracellular calcium could func- 
tion as a mediator of the growth factor signal [6]. 
It has also been shown that addition of a phor- 
bol ester [7], or a synthetic diacylglycerol [8] to 
cultured granulosa cells inhibited the production 
of oestradiol stimulated by FSH. Since both 
substances are known activators of protein kinase 
C, which is also calcium-dependent [9], the ob- 
served effects of EGF on aromatase activity in Ser- 
toli cells may be (partly) mediated by changes in 
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intracellular calcium and/or activation of protein 
kinase C. Therefore, we have studied the effect of 
EGF, the phorbol ester phorbol myristate acetate 
(PMA) and different extracellular calcium concen- 
trations on the FSH- or dcAMP-stimulated 
aromatase activity in Sertoli cells. 
2. MATERIALS AND METHODS 
EGF was a generous gift from Dr Rolando Perez 
(Instituto Nacional de Oncologia y Radiobiologia, 
Habana) and was obtained from mouse submax- 
illary glands as described [10]. Eagle's minimal 
essential medium (MEM), foetal calf serum (FCS) 
and a solution of non-essential mino acids were 
purchased from Gibco, Europe. Testosterone, 
dibutyryl adenosine 3 ' ,5 ' -monophosphate (dbc- 
AMP), 3-isobutyl-l-methylxanthine (IBMX), 4~'- 
phorbol-12-myristate-13-acetate (PMA), EGTA, 
oestradiol 
nglmg prot .  
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Hepes, deoxyribonuclease and collagenase were 
obtained from Sigma, London. FSH-NIH-S12 was 
a gift from the Endocrinology Study Section of the 
National Institute of Health (Bethesda, MD, 
USA). 
2.1. Isolation and culture of Sertoli cells 
Sertoli cells were isolated as described by Oonk 
et al. I l l ] ,  with slight modifications as reported 
earlier [4]. Briefly, decapsulated testes from 
16-day-old Wistar rats were dispersed twice in 
phosphate-buffered saline (PBS), containing 
0.5 mg/ml  collagenase and 20/~g/ml deox- 
yribonuclease, both times for 30 min at 37°C in a 
shaking water bath at approx. 80 cycles per min. 
The suspension of tubular fragments obtained, 
was washed several times in MEM supplemented 
with 20 mM Hepes, 1% FCS and antibiotics, until 
the supernatant was completely clear. The tubular 
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Fig. 1. Dose-dependent i hibition by EGF of FSH- and dcAMP-stimulated testosterone aromatization by cultured rat 
Sertoli cells. Cells were isolated and cultured as described in section 2. On day 5 fresh medium was added containing 
200 ng/ml testosterone (T) and either FSH (1/~g/ml) or dcAMP (0.2 mM) together with the indicated concentrations 
of EGF. Incubations were terminated after 24 h. Each point represents he mean +_ SD of 3 different cell preparations. 
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fragments were resuspended in the same culture 
medium and plated in 6-well culture dishes 
(Costar) at an approximate density of 600/zg of 
cellular protein per well. The cultures were main- 
tained at 37°C in a water vapour saturated at- 
mosphere of 5% CO2 and after 24 h of culture the 
dishes were washed and MEM without FCS was 
added. Washings and renewal of medium were 
repeated on days 3 and 4 of the culture period. 
After 4-5 days the cultures were confluent 
monolayers and consisted of more than 95% Ser- 
toli cells as evaluated by phase contrast 
microscopy. On day 5 the experiments were started 
by addition of the appropriate substances. When 
media-containing EGTA was used the pH was ad- 
justed to 7.4 by addition of NaOH. The ATP con- 
tent of the cells was measured by the procedure 
described by Lundin et al. [12]. In experiments 
where effects of EGTA, or PMA were determined, 
culture media were collected after various incuba- 
tion periods and kept at -20°C  until assay for 
oestradiol. 1 M NaOH was added to the dishes in 
order to dissolve the ceils. 
2.2. Measurement of oestradiol and protein 
Oestradiol concentration i culture media was 
determined following the method of Sufi et al. 
[13], with the exception that the ether extraction 
step was omitted after it had been demonstrated 
that this step had no effect on oestradiol evels 
measured. For estimation of the protein content of 
the cells, the procedure of Lowry et al. [14] was 
used. Experiments were repeated with at least 3 
different cell preparations. Student's t-test was 
used to assess the statistical significance of the 
observed effects. 
3. RESULTS 
The addition of EGF to Sertoli cell cultures in- 
hibited the stimulated oestradiol production in a 
dose-dependent way (fig.l). This effect was 
observed when aromatization was either 
stimulated by FSH or dcAMP and the amount of 
EGF required for the half maximal suppression 
was approximately the same in both cases (0.9 and 
0.5 nM EGF for FSH- and dcAMP-stimulated ac- 
tivity). The aromatase activity was only suppressed 
to 50o  of the original activity at the highest con- 
centrations of EGF. 
The inhibitory effect of EGF does not seem to be 
a result of increased phosphodiesterase activity 
since addition of the phosphodiesterase inhibitor 
IBMX had no effect on the actions of EGF (table 
1). Addition of EGTA to the culture media further 
increased the FSH- or dcAMP-stimulated 
oestradiol production, whereas in the presence of 
Table 1 
Effect of IBMX on testosterone aromatization by 
cultured Sertoli cells 
Additions Oestradiol 
(ng/mg protein) 
Test + FSH 
Test + FSH + IBMX 
Test + FSH + EGF 
Test + FSH + EGF + IBMX 
2.03 +_ 0.30 
2.20 _+ 0.17 
1.13 _+ 0.15 a 
1.16 + 0.05 ~ 
a Significantly different (p < 0.01) from cells incubated 
with testosterone and FSH 
Cells were isolated and cultured as described in section 
2. On day 5 the indicated substances were added to the 
cultures to give a final concentration as follows: 
testosterone (200 ng/ml), FSH (1/zg/ml), EGF 
(l/zg/ml), IBMX (0.2 mM). The incubations were 
terminated after 24 h. Values are the mean + SD of 
triplicate cultures 
Table 2 
Effect of EGF in the presence of different 
concentrations of extracellular calcium on FSH- or 
dcAMP-stimulated aromatization f added testosterone 
by cultured Sertoli cells 
Additions Oestradiol 
(ng/mg protein) 
FSH dcAMP 
(1/zg/ml) (0.2 mM) 
EGTA (3 mM) 
EGTA and CaCI2 (5 mM) 
EGF (1/~g/ml) 
EGF and EGTA 
EGF, 1 EGTA and CaC12 
2.58 + 0.07 3.31 +_ 0.20 
5.83 + 0.49a7.57 --- 0.83 a 
3.02 + 0.31 3.46 + 0.37 
1.09 _+ 0.01 a 1.50 +- 0.21 a 
5.17 + 0.46~7.20 + 0.57 
2.43 +- 0.25 
a Significantly different (p < 0.001) from cells incubated 
with testosterone and FSH or dcAMP 
For incubation conditions see table 1. Mean values + SD 
from 3 different cell preparations are shown 
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Fig.2. Dose-dependent i hibitory effect of phorbol ester PMA on FSH- and dcAMP-stimulated aromatization of 
testosterone. Sertoli ceils were cultured for 4 days without hormones. On day 5 fresh medium was added containing 
200 ng/ml testosterone (T) and either FSH (1 #g/ml) or dcAMP (0.2 mM) together with different concentrations of
PMA. Incubations were terminated after 24 h. Each point represents he mean +- SD of 3 different cell preparations. 
Significantly different (*p < 0.01, **p < 0.001) from cells incubated without PMA. 
EGTA EGF did not exert any inhibitory effects 
(table 2). These stimulating effects of EGTA were 
abolished after addition of CaCI2 (table 2) and 
could not be shown in the absence of FSH or 
dcAMP (not shown). When Sertoli cells were in- 
cubated in the presence of different doses of the 
phorbol ester PMA, the FSH- and the dcAMP- 
stimulated oestradiol production was inhibited in a 
similar fashion to that with EGF (fig.2). The in- 
hibitory effect of PMA was most probably not 
caused by cell damage since ATP levels in Sertoli 
cells incubated with PMA were not different from 
controls (not shown). 
4. DISCUSSION 
The results presented in this study show that 
aromatase activity in Sertoli cells, stimulated by 
FSH or dcAMP can be partly inhibited by EGF 
and that these hormonal effects can be modulated 
by extracellular calcium. The mechanisms involved 
in these calcium-dependent EGF effects on Sertoli 
cell function and the possible physiological im- 
plications are still unknown, although inhibitory 
effects of EGF on steroidogenesis in Leydig cells 
[15], ovarian interstitial cells [16] and granulosa 
cells [17] have been reported earlier. 
Studies on the primary effects of EGF carried 
out with fibroblasts and A431 cells have shown 
that EGF causes a transient increase in in- 
tracellular calcium levels provided that normal ex- 
tracellular calcium concentrations are present 
[6,18]. For EGF action on Sertoli cells similar 
mechanisms may operate. An important argument 
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in favour of this hypothesis is that inhibitory ef- 
fects of EGF could not be demonstrated when ex- 
tracellular calcium was low. This presumed 
EGF-induced increase in intracellular calcium 
could activate a specific calcium-dependent 
phosphodiesterase [19] or enhance protein kinase 
C activity. 
The first possibility seems unlikely for two 
reasons: (i) the phosphodiesterase inhibitor IBMX 
could not reduce the inhibitory effects of EGF and 
(ii) EGF can inhibit aromatase activity stimulated 
by an excess of dcAMP. 
On the other hand the similarities between the 
inhibitory effects of EGF and the phorbol ester 
PMA and the observed effects of manipulations 
with extracellular calcium reinforce the hypothesis 
that EGF may activate protein kinase C in Sertoli 
cells (in part) via regulation of intracellular 
calcium. This suggestion is further supported by 
the observation that phorbol esters and EGF can 
inhibit oestrogen production in granulosa cells 
[8,161. 
Due to the limited number of experiments car- 
ried out with gonadal cells, it is unknown which 
mechanisms may play a role in protein kinase C- 
mediated regulation of oestradiol production in 
gonadal cells. However, in KB cells calcium and 
protein kinase C can reduce the affinity of the EGF 
receptor for EGF, probably via receptor 
phosphorylation [20,21]. It has been reported that 
Sertoli cells can secrete a growth factor that can 
block binding of EGF to EGF receptors [22]. 
Therefore it may be possible that under in vitro 
conditions, and perhaps in vivo as well, this Sertoli 
cell growth factor can negatively control, in an 
autocrine fashion, the FSH-induced aromatase ac- 
tivity via protein kinase C and calcium. This model 
could explain why the stimulation of aromatase by 
FSH or dcAMP is more pronounced in the absence 
of calcium. This hypothesis can be tested further 
by studies on the binding of EGF to Sertoli cell 
receptors under the influence of EGF with or 
without calcium present. 
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